(MENAFN- Prophecy Market Insights ) Global Genital Herpes Market accounted for US$ 169.5 million in 2020 and is estimated to be US$ 261.5 million by 2030 and is anticipated to register a CAGR of 4.50%. Herpes simplex is a sexually transmitted infection caused by the herpes simplex virus. HSV-1, which is located around the mouth, and HSV-2, which is found around the vaginal area, are the two types. Herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) causes genital herpes, which is the major cause of genital ulcers. HSV-1 causes non-sexually transmitted oral herpes infection and is usually detected around the mouth (cold sores). HSV-1 is a virus that causes labial or pharyngeal infection and is spread mostly through non-genital contact. Though HSV-1 can be transmitted to the genitals through oral intercourse, infections with the virus can also occur as a result of everyday interactions such as sharing utensils, sharing lip balm, or kissing. HSV-2 is a sexually transmitted virus that usually affects the vaginal area.
The report " Global Genital Herpes Market, By Drug (Acyclovir, Valacyclovir, Famciclovir and Others), By Route of Administration (Oral, Injection and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’
Key Highlights:
In 2021, GlaxoSmithKline (GSK) has launched a limited phase 1 clinical trial for HSV vaccine, a potential for treating herpes simplex virus type 2 (HSV-2) (GSK4108771A). This study, which will take place in the United States and will have sixty participants.
In 2021, Nurx has recently added prescription skincare services, such as treatment for acne, rosacea, and sun-related ageing, as well as a variety of sexual health services, such as home testing and treatment for sexually transmitted infections, treatment for oral and genital herpes, home HPV testing as a Pap smear alternative for women 30 and older, and PrEP, a daily pill that is up to 99 percent effective in ensuring HIV-negative people.
Analyst View:
The key factors driving the market's growth are an increase in the prevalence of sexually transmitted diseases, an increase in the use of herpes treatment, an increase in awareness of sexually transmitted diseases, an increase in the use of targeted herpes treatment procedures, an increase in hospital acquired infections, and an increase in demand for effective therapeutic treatment. Furthermore, an increase in government funding to develop innovative treatments for genital herpes, an increase in demand for minimally invasive treatment procedures, an increase in the development of antiviral resistant species, R&D activities to improve the quality of drug treatment methods, and joint ventures and collaboration between key market players are all contributing to the growth of the industry.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Genital Herpes Market, By Drug (Acyclovir, Valacyclovir, Famciclovir and Others), By Route of Administration (Oral, Injection and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”
To know the upcoming trends and insights prevalent in this market, click the link below:
Key Market Insights from the report:
Global Genital Herpes Market accounted for US$ 169.5 million in 2020 and is estimated to be US$ 261.5 million by 2030 and is anticipated to register a CAGR of 4.50%. The Global Genital Herpes Market is segmented based on drug type, route of administration, distribution channel and region.
Based on Drug Type, Global Genital Herpes Market is segmented into Acyclovir, Valacyclovir, Famciclovir and Others.
Based on Route of Administration, Global Genital Herpes Market is segmented into Oral, Injection and Topical.
Based on Distribution Channel, Global Genital Herpes Market is segmented into Hospital Pharmacy, Retail Pharmacy, Others.
By Region, the Global Genital Herpes Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape & their strategies of Global Genital Herpes Market:
Some of the companies which are currently dominating the market are Teva Pharmaceuticals Inc., Apotex Inc., Mylan Pharmaceuticals Inc., Epi Health LLC, Zydus Pharmaceuticals, GlaxoSmithKline LLC, Carlsbad Tech, Avet Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc. and Fresenius Kabi. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
Some Important Points Answered in this Market Report Are Given Below:
Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
To know more
Contact Us:
Sales
Prophecy Market Insights
1 860 531 2701
Email- sales@prophecymarketinsights.com
Website-
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.